Novel Antiviral Therapies

Antiviral therapy is one of the most exciting aspects of virology, since it has successfully employed basic science to generate very effective treatments for serious viral infections. Most drugs and vaccines, however, selectively target a single virus, thereby providing a “one drug-one bug” solution. In contrast, broad-spectrum antivirals (BSAs) can cover multiple viruses and genotypes and reduce the likelihood of development of resistance. Therefore, some BSAs can be used for the rapid management of new or drug-resistant viral strains, for a first-line treatment. There are two types of anti-viral therapies depending on the type of virus, they are: "episodic" oral antiviral therapy (where antiviral therapy is used intermittently by the patient during a recurrence), or "suppressive" antiviral therapy (where the antiviral therapy is taken continuously to prevent recurrences).

    Related Conference of Novel Antiviral Therapies

    March 18-19, 2024

    53rd World Congress on Microbiology

    Zurich, Switzerland
    May 09-10, 2024

    16th International Virology Summit

    Barcelona, Spain
    June 10-11, 2024

    5th International Conference on Molecular Microbiology

    Barcelona, Spain

    Novel Antiviral Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in